Suven Life Sciences bags Pharmexcil’s ‘Gold Patent Award’ for NCE’s

23 Sep 2014 Evaluate

Suven Life Sciences (SUVEN) has bagged Pharmexcil’s ‘Gold Patent Award’ for securing the most number of product patents under NCE category and ‘Outstanding Export Performance Award’ for Contract Research and Manufacturing. The awards were presented during the Awards Function for Exports and patents during 10th Annual General Meet of Pharmexcil at Hyderabad.

Suven secured 76 product patents for their NCE’s during 2013-2014 from several countries including all the developed countries like USA, Europe, Japan, Australia and Canada etc. So far Suven secured a total of 676 product patents globally for their NCE’s and 36 process patents.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets.

Suven Life Sciences Share Price

166.05 -1.75 (-1.04%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×